167 related articles for article (PubMed ID: 10160470)
21. Cost-benefit analysis of sumatriptan tablets versus usual therapy for treatment of migraine.
Biddle AK; Shih YC; Kwong WJ
Pharmacotherapy; 2000 Nov; 20(11):1356-64. PubMed ID: 11079284
[TBL] [Abstract][Full Text] [Related]
22. Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan.
Pradalier A; Lutz G; Vincent D
Headache; 2000 Apr; 40(4):324-7. PubMed ID: 10759939
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of migraine treatment: a commentary.
Smith DG
Value Health; 2003; 6(4):436-7. PubMed ID: 12859584
[No Abstract] [Full Text] [Related]
24. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of the acute migraine attack].
Titus F
Rev Neurol; 1995; 23 Suppl 2():S203-7. PubMed ID: 7497289
[No Abstract] [Full Text] [Related]
26. Cost savings in migraine associated with less chest pain on new triptan therapy.
Wang JT; Barr CE; Torigoe Y; Wang E; Rowland CR; Goldfarb SD
Am J Manag Care; 2002 Feb; 8(3 Suppl):S102-7. PubMed ID: 11859905
[TBL] [Abstract][Full Text] [Related]
27. The hospital management of severe migrainous headache.
Jauslin P; Goadsby PJ; Lance JW
Headache; 1991 Nov; 31(10):658-60. PubMed ID: 1663091
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the acute management of migraine and cluster headaches.
Kumar KL
J Gen Intern Med; 1994 Jun; 9(6):339-48. PubMed ID: 8078000
[TBL] [Abstract][Full Text] [Related]
29. Cost benefit of sumatriptan to an employer.
Legg RF; Sclar DA; Nemec NL; Tarnai J; Mackowiak JI
J Occup Environ Med; 1997 Jul; 39(7):652-7. PubMed ID: 9253726
[TBL] [Abstract][Full Text] [Related]
30. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
Dahlöf C; Maassen Van Den Brink A
Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
[TBL] [Abstract][Full Text] [Related]
31. Different approaches to valuing the lost productivity of patients with migraine.
Lofland JH; Locklear JC; Frick KD
Pharmacoeconomics; 2001; 19(9):917-25. PubMed ID: 11700778
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
[TBL] [Abstract][Full Text] [Related]
33. MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine.
Silberstein S
Expert Opin Pharmacother; 2012 Sep; 13(13):1961-8. PubMed ID: 22860628
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine.
Evans KW; Boan JA; Evans JL; Shuaib A
Pharmacoeconomics; 1997 Nov; 12(5):565-77. PubMed ID: 10174323
[TBL] [Abstract][Full Text] [Related]
35. NerveCenter: Sumatriptan's evolution from brand drug to best buy of 2010.
Stone K
Ann Neurol; 2010 Sep; 68(3):A10-1. PubMed ID: 20818778
[No Abstract] [Full Text] [Related]
36. [Treatment of transformed refractory migraine with intravenous dihydroergotamine].
Cid C; Ortega-Valín F; Valero M; Muñoz R; Pascual J
Neurologia; 1999; 14(6):315-8. PubMed ID: 10439626
[TBL] [Abstract][Full Text] [Related]
37. HMO direct costs and health care resources use after implementation of a monthly limit on sumatriptan.
Goldfarb SD; Duncan BS; Dans PE; Sloan AS
Am J Health Syst Pharm; 1999 Nov; 56(21):2206-10. PubMed ID: 10565699
[TBL] [Abstract][Full Text] [Related]
38. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
39. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
[TBL] [Abstract][Full Text] [Related]
40. Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.
Silberstein SD; Kori SH
CNS Drugs; 2013 May; 27(5):385-94. PubMed ID: 23620146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
